ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2022
[Randomized phase II study of PET response-adapted combined multimodal therapy for esophageal cancer: results of the CALGB 80803 (Alliance) trial].
Lukas Bauer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.